rs41301291
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000369486.8(IGSF3):c.2698G>A(p.Val900Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,614,228 control chromosomes in the GnomAD database, including 267 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000369486.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGSF3 | NM_001007237.3 | c.2698G>A | p.Val900Met | missense_variant | 9/11 | ENST00000369486.8 | NP_001007238.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGSF3 | ENST00000369486.8 | c.2698G>A | p.Val900Met | missense_variant | 9/11 | 1 | NM_001007237.3 | ENSP00000358498 | P4 | |
IGSF3 | ENST00000318837.6 | c.2758G>A | p.Val920Met | missense_variant | 9/11 | 2 | ENSP00000321184 | A1 | ||
IGSF3 | ENST00000369483.5 | c.2758G>A | p.Val920Met | missense_variant | 10/12 | 5 | ENSP00000358495 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0137 AC: 2091AN: 152240Hom.: 29 Cov.: 33
GnomAD3 exomes AF: 0.0164 AC: 4114AN: 251430Hom.: 55 AF XY: 0.0164 AC XY: 2235AN XY: 135896
GnomAD4 exome AF: 0.0156 AC: 22748AN: 1461870Hom.: 238 Cov.: 31 AF XY: 0.0155 AC XY: 11243AN XY: 727232
GnomAD4 genome AF: 0.0137 AC: 2088AN: 152358Hom.: 29 Cov.: 33 AF XY: 0.0139 AC XY: 1037AN XY: 74498
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at